Browse studies

Find your next paid study

27,273 recruiting studies available now

Effects of Fiber-Enriched Soda on Postprandial Heart Disease Risk Factors

We are examining whether consuming a fiber-enriched soda (Olipop) before a high-fat meal leads to a more favorable cardiometabolic response than when consuming…

Healthy Participants

Estimated

~$10 – $750

Actual pay is set by the research site.

Ball State UniversityNCT07882264

Phase 1

A Phase 1/2 Clinical Study to Evaluate the Optimal Dose and the Protective Effect of CMV-MVA Triplex Vaccine in Pediatric Patients Receiving an Allogeneic Hematopoietic Stem Cell Transplant

This phase I/II trial studies the side effects and best dose of multi-antigen cytomegalovirus (CMV)-modified vaccinia ankara vaccine and to see how well it wor…

Cytomegaloviral InfectionHematopoietic Cell Transplant Recipient

Estimated

~$150 – $3,000

Actual pay is set by the research site.

City of Hope Medical CenterNCT03354728

Phase 1

Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2

An exploratory, randomized, double-blinded, placebo-controlled, two-center clinical trial to determine the maximum tolerated dosage of intravenous tirofiban in…

Aneurysmal Subarachnoid Hemorrhage

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Dr David Hasan, M.D.NCT07493577

Phase 3

A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab With Open-Label Induction, Randomized Double-Blind Maintenance, and Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) With Moderately to Severely Active Crohn's Disease

Crohn's Disease (CD) is a gastrointestinal disease that can cause chronic diarrhea with or without gross bleeding, abdominal pain, weight loss, and fever. This…

Crohn's Disease

Estimated

~$50 – $2,250

Actual pay is set by the research site.

AbbVieNCT05995353

Phase 1

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TVB-3567 in Healthy Participants With or Without Acne and to Assess the Effect of Food in Healthy Participants

This is a 4-part study. Part A will be a randomized, double-blind, placebo-controlled investigation of single ascending doses (SAD) to assess the safety, toler…

Acne

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Sagimet Biosciences Inc.NCT06989840

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

This prospective longitudinal study will compare incidence rates of Medicare beneficiary surgical and minimally invasive intervention post index procedure, as …

Lumbar Spinal Stenosis

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Stryker InstrumentsNCT03072927

Observational

Randomized Placebo-controlled Trial of Nicotine Pouches in Smokers

The purpose of this clinical trial is to understand the health effects of a new oral nicotine pouch, and also to understand if this product can help reduce tra…

Tobacco Dependence

Estimated

~$10 – $750

Actual pay is set by the research site.

Milton S. Hershey Medical CenterNCT06043362

Phase 1

A Randomized, Double-blind, Placebo-controlled Single Ascending Dose and Open-label Multi-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ALN-APP in Adult Patients With Early-onset Alzheimer's Disease (EOAD)

The purpose of this study is to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of a single dose and multiple doses of ALN-A…

Early-Onset Alzheimer Disease

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Alnylam PharmaceuticalsNCT05231785

Phase 1

A Phase 1b Open-Label Study to Evaluate the Safety and Tolerability of Eganelisib as Monotherapy and in Combination With Cytarabine in Patients With Relapsed/Refractory Acute Myeloid Leukemia or Higher Risk Myelodysplastic Syndrome and Eganelisib in Combination With Azacitidine in PI3K-Gamma-Positive Patients With Previously Untreated Higher Risk Myelodysplastic Syndrome

This is a Phase 1b open-label, multicenter, dose-escalation and randomized combination cohort study designed to evaluate the safety, tolerability, pharmacokine…

AML, AdultMDS

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Stelexis BioSciencesNCT06533761

Paradoxical Tuberculosis Reactions in Patients Without HIV Infection

Background: Most people with tuberculosis (TB) feel better after starting treatment. But for some people, the opposite happens. They may feel better at first,…

Tuberculosis

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Allergy and Infectious Diseases (NIAID)NCT04052022

Observational

Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium

The objective of this study is to evaluate the safety, tolerability, and preliminary efficacy of the Motif eXternally powered Cortical Stimulation (XCS) System…

Major Depressive Disorder

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Motif Neurotech, Inc.NCT07594483

Phase 2

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Confirm Efficacy and Safety of MH002 and to Assess the Effect of Dose in Patients With Mild-to- Moderate Ulcerative Colitis Insufficiently Controlled With 5-Aminosalicylic Acid

The main goal of the study is to check if MH002 works and is safe to use. In a previous study in 45 patients with Ulcerative Colitis, MH002 was found to have f…

Colitis, Ulcerative

Estimated

~$75 – $3,000

Actual pay is set by the research site.

MRM Health NVNCT07296315